Lovenox (enoxaparin sodium) Injection

Company
Rhone Poulenc Rorer

Approval Status
Approved January 1999

Treatment for
Hematology

Possible similar drugs
Lovenox; Lovenox

Areas
Hematology

Lovenox has been approved for the following indications: (1) the inpatient treatment of acute deep vein thrombosis with and without pulmonary embolism, when administered in conjunction with warfarin sodium, and (2) the outpatients treatment of acute deep vein thrombosis without pulmonary embolism when administered in conjunction with warfarin sodium.

Lovenox_551 Drug Information

The Lovenox_551 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top